Paid Clinical Trials in Oklahoma

Oklahoma has 836 paid clinical trials enrolling now across cities including Oklahoma City, Tulsa and Edmond. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

State

City

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

836 clinical trials

↓ Download CSV

A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

for Asthma

11 locations incl. Bakersfield

Sponsor: AstraZeneca

Sex: All·Age: 4 - 11

Code: NCT07525375·Phase 2·Recruiting

Apply to this trial

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

for Systemic Lupus Erythematosus

25 locations incl. Anniston

Sponsor: AstraZeneca

Sex: All·Age: 18 - 70

Code: NCT07430306·Phase 3·Recruiting

Apply to this trial

Phase 3 Trial of VMX-C001 vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.

for Blood Loss, Surgical

16 locations incl. Chandler

Sponsor: VarmX B.V.

Sex: All·Age: 18+

Code: NCT07288489·Phase 3·Not Yet Recruiting

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

for Macular Degeneration

30 locations incl. Springdale

Sponsor: EyeBiotech Ltd.

Sex: All·Age: 50+

Code: NCT07440225·Phase 2, Phase 3·Recruiting

Apply to this trial

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

for Obesity or Overweight

Drug: Enicepatide

28 locations incl. Guntersville

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT07351058·Phase 3·Recruiting

Apply to this trial

The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms

for Hemorrhagic Stroke

17 locations incl. Phoenix

Sponsor: phenox Inc.

Sex: All·Age: 18+

Code: NCT07143019·Recruiting

Apply to this trial

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

for Non-Small Cell Lung Cancer (NSCLC)

Drug: Pumitamig

40 locations incl. Daphne

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT07361510·Phase 3·Recruiting

Apply to this trial

An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps

for Chronic Rhinosinusitis With Nasal Polyps

2 locations incl. La Mesa

Sponsor: Sanofi

Sex: All·Age: 18+

Code: NCT07424144·Phase 3·Enrolling By Invitation

Skeletal Muscle Aging and Responsiveness in Aged People With MS

for Multiple Sclerosis

1 location in Oklahoma City

Sponsor: Oklahoma Medical Research Foundation

Sex: All·Age: 60+

Code: NCT07500727·Recruiting

Apply to this trial

Promoting Active Living Among People With Metastatic Breast Cancer

for Metastatic Invasive Breast Cancer

1 location in Oklahoma City

Sponsor: University of Oklahoma

Sex: All·Age: 18 - 99

Code: NCT07238023·Recruiting

Apply to this trial

Feasibility Study for Repurposing RET Inhibitors

for Cachexia-Anorexia Syndrome

1 location in Oklahoma City

Sponsor: University of Oklahoma

Sex: All·Age: 18+

Code: NCT07146893·EARLY_Phase 1·Not Yet Recruiting

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

for Schizophrenia

Drug: KarXT

45 locations incl. Bryant

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT07379827·Recruiting

Apply to this trial

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

for Parkinson Disease

25 locations incl. Little Rock

Sponsor: Appello Pharmaceuticals, Inc.

Sex: All·Age: 30 - 80

Code: NCT07432958·Phase 2·Recruiting

Apply to this trial

A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

for Systemic Lupus Erythematosus (SLE)

Drug: Deucravacitinib

4 locations incl. Farmington

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18 - 75

Code: NCT06875960·Phase 4·Recruiting

Apply to this trial

Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)

for Cigar Smoking

2 locations incl. Oklahoma City

Sponsor: University of Oklahoma

Sex: All·Age: 18 - 24·Accepts healthy volunteers

Code: NCT07162935·Recruiting

Apply to this trial

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

for Locally Advanced Adrenal Cortical Carcinoma

Drug: Cabozantinib

69 locations incl. La Jolla

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 12+

Code: NCT06900595·Phase 2·Recruiting

Apply to this trial

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain

for Diabetic Peripheral Neuropathic Pain

Drug: LY4065967

36 locations incl. Birmingham

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07285018·Phase 2·Recruiting

Apply to this trial

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

for Ovarian Neoplasms

7 locations incl. Miami Beach

Sponsor: Merck Sharp & Dohme LLC

Sex: Female·Age: 18+

Code: NCT07318558·Phase 3·Recruiting

Apply to this trial

COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

for Diabetic Macular Edema

Drug: Aflibercept

50 locations incl. Bakersfield

Sponsor: EyePoint Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT07449936·Phase 3·Recruiting

Apply to this trial

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

for Ampulla of Vater Carcinoma

309 locations incl. Phoenix

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07283939·Recruiting

Apply to this trial

A Study of Brenipatide in Participants With Opioid Use Disorder

for Opioid Use Disorder

Drug: Brenipatide

38 locations incl. Phoenix

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 75

Code: NCT07420283·Phase 2·Recruiting

Apply to this trial

A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)

for MASH - Metabolic Dysfunction-Associated Steatohepatitis

31 locations incl. Chandler

Sponsor: Rivus Pharmaceuticals, Inc.

Sex: All·Age: 30+

Code: NCT07491458·Phase 2·Recruiting

Apply to this trial

Program in Oncology for Tribal Health Systems.

for Patient Outcomes

1 location in Oklahoma City

Sponsor: University of Oklahoma

Sex: All·Age: 18+

Code: NCT07217574·Recruiting

Apply to this trial

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

for Osteoarthritis

Drug: Eloralintide

37 locations incl. Mobile

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07353931·Phase 3·Recruiting

Apply to this trial

A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

for Uncontrolled Gout

48 locations incl. Birmingham

Sponsor: Amgen

Sex: All·Age: 18+

Code: NCT07388498·Phase 3·Recruiting

Apply to this trial

CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

for Diabetic Macular Edema

Drug: Aflibercept

48 locations incl. Gilbert

Sponsor: EyePoint Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT07449923·Phase 3·Recruiting

Apply to this trial

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

for Type II Diabetes Mellitus

31 locations incl. Birmingham

Sponsor: Corxel Pharmaceuticals

Sex: All·Age: 18 - 75

Code: NCT07340320·Phase 2·Recruiting

Apply to this trial

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

for Type 1 Diabetes Mellitus

10 locations incl. Los Angeles

Sponsor: Mannkind Corporation

Sex: All·Age: 10 - 17

Code: NCT07224321·Phase 2·Recruiting

Apply to this trial

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

for Bipolar I Disorder

Drug: Icalcaprant

31 locations incl. Huntsville

Sponsor: AbbVie

Sex: All·Age: 18 - 65

Code: NCT06696755·Phase 2·Recruiting

Apply to this trial

Postural Control in Adults

for Older

1 location in Oklahoma City

Sponsor: University of Oklahoma

Sex: All·Age: 65 - 80·Accepts healthy volunteers

Code: NCT07554118·Recruiting

Apply to this trial

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

for Eosinophilic Asthma

20 locations incl. Long Beach

Sponsor: Kymera Therapeutics, Inc.

Sex: All·Age: 18 - 75

Code: NCT07323654·Phase 2·Recruiting

Apply to this trial

Breath Hydrogen and Methane as Biomarkers of Fiber Intake

for Healthy Eating

1 location in Oklahoma City

Sponsor: University of Oklahoma

Sex: All·Age: 18 - 80

Code: NCT07375329·Enrolling By Invitation

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

for Advanced Endometrial Carcinoma

Drug: Bevacizumab

211 locations incl. Birmingham

Sponsor: National Cancer Institute (NCI)

Sex: Female·Age: 18+

Code: NCT07198074·Phase 3·Recruiting

Apply to this trial

A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)

for Graves' Disease

Drug: IMVT-1402

89 locations incl. Phoenix

Sponsor: Immunovant Sciences GmbH

Sex: All·Age: 18+

Code: NCT07286006·Phase 2·Enrolling By Invitation

Neoadjuvant Darovasertib in Primary Uveal Melanoma

for Uveal Melanoma

35 locations incl. Scottsdale

Sponsor: IDEAYA Biosciences

Sex: All·Age: 18+

Code: NCT07015190·Phase 3·Recruiting

Apply to this trial

Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis

for Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis

Drug: Vamifeport

18 locations incl. Gilbert

Sponsor: CSL Behring

Sex: All·Age: 18+

Code: NCT07332091·Phase 2·Recruiting

Apply to this trial

Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

for Type II Diabetes Mellitus

9 locations incl. Little Rock

Sponsor: Sun Pharmaceutical Industries Limited

Sex: All·Age: 18+

Code: NCT07282743·Phase 2·Recruiting

Apply to this trial

Circulating Tumor DNA Response In Urothelial Cancer

for Urothelial Carcinoma

1 location in Oklahoma City

Sponsor: University of Oklahoma

Sex: All·Age: 18+

Code: NCT07183319·Phase 2·Recruiting

Apply to this trial

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

for Cervical Cancer

16 locations incl. Miami Beach

Sponsor: Merck Sharp & Dohme LLC

Sex: Female·Age: 18+

Code: NCT07216703·Phase 3·Recruiting

Apply to this trial

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

for Malignant Digestive System Neoplasm

58 locations incl. Fort Smith

Sponsor: Wake Forest University Health Sciences

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07215624·Recruiting

Apply to this trial